Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: evaluation report

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

 

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: evaluation report

01. Pre-meeting Briefing

02. ERG report - Warwick Evidence

03. ERG group report - factual accuracy check

04. Manufacturer submission - Bayer

05. Manufacturer PAS Submission - Bayer

06. NICE request for clarification

07. Clarification response

08. Organisation submission - RNIB

09. Organisation submission - Royal College Of Opthalmologists

10. Expert personal perspective - CEaglen

11. Expert personal perspective - CYelf

12. Expert personal perspective - IPearce

13. Expert personal perspective - SSivaprasad

 

* Users of Google chrome should click the link below and then click the small PDF icon in the far right of the address bar to successfully access this document *

 

This page was last updated: 08 January 2014